Cargando…

Innovative antimicrobial coating of titanium implants with iodine

BACKGROUND: Postoperative infection associated with implants remains a serious complication in orthopedic surgery. Several biomaterial surface treatments have been proposed as a means of reducing the incidence of implant-associated infections. In this study, a clinical trial was performed using an i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuchiya, Hiroyuki, Shirai, Toshiharu, Nishida, Hideji, Murakami, Hideki, Kabata, Tamon, Yamamoto, Norio, Watanabe, Koji, Nakase, Junsuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462916/
https://www.ncbi.nlm.nih.gov/pubmed/22806173
http://dx.doi.org/10.1007/s00776-012-0247-3
_version_ 1782245224823652352
author Tsuchiya, Hiroyuki
Shirai, Toshiharu
Nishida, Hideji
Murakami, Hideki
Kabata, Tamon
Yamamoto, Norio
Watanabe, Koji
Nakase, Junsuke
author_facet Tsuchiya, Hiroyuki
Shirai, Toshiharu
Nishida, Hideji
Murakami, Hideki
Kabata, Tamon
Yamamoto, Norio
Watanabe, Koji
Nakase, Junsuke
author_sort Tsuchiya, Hiroyuki
collection PubMed
description BACKGROUND: Postoperative infection associated with implants remains a serious complication in orthopedic surgery. Several biomaterial surface treatments have been proposed as a means of reducing the incidence of implant-associated infections. In this study, a clinical trial was performed using an iodine-supported titanium that suppresses the microbial activities. METHODS: A total of 222 patients with postoperative infection or compromised status were treated using iodine-supported titanium implants. The mean age of the patients was 49.4 years (range 5–85 years). One hundred twenty-seven patients were male and 95 were female. In 158 patients, iodine-supported implants were used to prevent infection, such as compromised hosts and conditions, and in 64 patients to treat active infection. White blood cell (WBCs) and C-reactive protein (CRP) levels were measured pre- and postoperatively in all patients. To confirm whether iodine from the implant affected physiological functions, thyroid hormone levels in the blood were examined. Both examinations were conducted sequentially for a year. Radiological evaluations were performed regularly after the operation. The chronological changes of the iodine amount were evaluated using half pins removed after completion of external fixation. RESULTS: The mean follow-up period was 18.4 months (range 3–44 months). Acute infection developed in three tumor cases among the 158 patients on preventive therapy. All three recovered without removal of the implants. Infection was cured in all 64 patients with infection. Median WBC levels were in the normal range, and median CRP levels returned to <0.5 within 4 weeks after surgery. Abnormalities of thyroid gland function were not detected. None of the patients experienced loosening of the implants. There were two patients with mechanical implant failure, which was treated by re-implantation. Excellent bone ingrowth and ongrowth were found around all hip and tumor prostheses. One year later, the amount of iodine on external fixation pins remained about 20–30 %. CONCLUSIONS: Iodine-supported titanium implants can be very effective for preventing and treating infections after orthopedic surgery. Cytotoxicity and adverse effects were not detected.
format Online
Article
Text
id pubmed-3462916
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Springer Japan
record_format MEDLINE/PubMed
spelling pubmed-34629162012-10-03 Innovative antimicrobial coating of titanium implants with iodine Tsuchiya, Hiroyuki Shirai, Toshiharu Nishida, Hideji Murakami, Hideki Kabata, Tamon Yamamoto, Norio Watanabe, Koji Nakase, Junsuke J Orthop Sci Original Article BACKGROUND: Postoperative infection associated with implants remains a serious complication in orthopedic surgery. Several biomaterial surface treatments have been proposed as a means of reducing the incidence of implant-associated infections. In this study, a clinical trial was performed using an iodine-supported titanium that suppresses the microbial activities. METHODS: A total of 222 patients with postoperative infection or compromised status were treated using iodine-supported titanium implants. The mean age of the patients was 49.4 years (range 5–85 years). One hundred twenty-seven patients were male and 95 were female. In 158 patients, iodine-supported implants were used to prevent infection, such as compromised hosts and conditions, and in 64 patients to treat active infection. White blood cell (WBCs) and C-reactive protein (CRP) levels were measured pre- and postoperatively in all patients. To confirm whether iodine from the implant affected physiological functions, thyroid hormone levels in the blood were examined. Both examinations were conducted sequentially for a year. Radiological evaluations were performed regularly after the operation. The chronological changes of the iodine amount were evaluated using half pins removed after completion of external fixation. RESULTS: The mean follow-up period was 18.4 months (range 3–44 months). Acute infection developed in three tumor cases among the 158 patients on preventive therapy. All three recovered without removal of the implants. Infection was cured in all 64 patients with infection. Median WBC levels were in the normal range, and median CRP levels returned to <0.5 within 4 weeks after surgery. Abnormalities of thyroid gland function were not detected. None of the patients experienced loosening of the implants. There were two patients with mechanical implant failure, which was treated by re-implantation. Excellent bone ingrowth and ongrowth were found around all hip and tumor prostheses. One year later, the amount of iodine on external fixation pins remained about 20–30 %. CONCLUSIONS: Iodine-supported titanium implants can be very effective for preventing and treating infections after orthopedic surgery. Cytotoxicity and adverse effects were not detected. Springer Japan 2012-07-18 2012 /pmc/articles/PMC3462916/ /pubmed/22806173 http://dx.doi.org/10.1007/s00776-012-0247-3 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Original Article
Tsuchiya, Hiroyuki
Shirai, Toshiharu
Nishida, Hideji
Murakami, Hideki
Kabata, Tamon
Yamamoto, Norio
Watanabe, Koji
Nakase, Junsuke
Innovative antimicrobial coating of titanium implants with iodine
title Innovative antimicrobial coating of titanium implants with iodine
title_full Innovative antimicrobial coating of titanium implants with iodine
title_fullStr Innovative antimicrobial coating of titanium implants with iodine
title_full_unstemmed Innovative antimicrobial coating of titanium implants with iodine
title_short Innovative antimicrobial coating of titanium implants with iodine
title_sort innovative antimicrobial coating of titanium implants with iodine
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462916/
https://www.ncbi.nlm.nih.gov/pubmed/22806173
http://dx.doi.org/10.1007/s00776-012-0247-3
work_keys_str_mv AT tsuchiyahiroyuki innovativeantimicrobialcoatingoftitaniumimplantswithiodine
AT shiraitoshiharu innovativeantimicrobialcoatingoftitaniumimplantswithiodine
AT nishidahideji innovativeantimicrobialcoatingoftitaniumimplantswithiodine
AT murakamihideki innovativeantimicrobialcoatingoftitaniumimplantswithiodine
AT kabatatamon innovativeantimicrobialcoatingoftitaniumimplantswithiodine
AT yamamotonorio innovativeantimicrobialcoatingoftitaniumimplantswithiodine
AT watanabekoji innovativeantimicrobialcoatingoftitaniumimplantswithiodine
AT nakasejunsuke innovativeantimicrobialcoatingoftitaniumimplantswithiodine